B-cell receptor specific for H5 hemagglutinin (BCR-H5HA) (BCR-H5HA)

B-cell receptors (BCRs) specific for H5 hemagglutinin (HA) epitopes are specialized membrane-bound immunoglobulins on the surface of B lymphocytes that recognize the H5 glycoprotein of influenza A viruses, such as the H5N1 subtype (PubMed: 29439208). These receptors are central to the adaptive immune response, as their engagement by viral antigens or vaccines triggers B-cell activation, proliferation, and differentiation into plasma cells that secrete H5-specific neutralizing antibodies (Janeway's Immunobiology). In the context of pandemic preparedness, these BCRs are the primary targets for H5N1 vaccines, which aim to elicit protective immunity against highly pathogenic avian influenza (HPAI) (CDC, 2024). Therapeutic strategies often focus on epitopes within the conserved stem region of the HA protein to stimulate the production of broadly neutralizing antibodies (bnAbs) that provide cross-clade protection (Nature Communications, 2018). Understanding the structural basis of BCR-H5 HA interactions is crucial for designing universal influenza vaccines that can overcome the challenges of antigenic drift and shift (Science, 2015).

Other names

H5-specific B-cell receptorAnti-H5 HA BCRH5N1 hemagglutinin-specific B-cell receptorH5 HA-reactive BCR

Antigenic stimulation of H5-specific B-cell receptors triggers intracellular signaling cascades (e.g., via Syk and PLC-gamma-2) that drive B-cell maturation, isotype switching, and the generation of high-affinity antibodies and memory B cells.